| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Long.term potentiation |
8 genes: GRIN2A, PPP1R12A, PLCB4, PPP1CC, PRKACB, RAP1A, RAP1B, CACNA1C
|
9.214e-05 |
| Ras signaling pathway |
14 genes: FGF2, FGF7, FGF12, FGF13, IGF1, HGF, INSR, PDGFRA, KIT, PRKACB, GRIN2A, SHOC2, RAP1A, RAP1B
|
0.0003984 |
| Focal adhesion |
11 genes: COL4A4, DOCK1, HGF, IGF1, MYLK, PPP1R12A, PDGFRA, PPP1CC, RAP1A, RAP1B, CCND2
|
0.00294 |
| Endocytosis |
11 genes: VPS37A, ERBB4, RAB11FIP2, DNM3, KIT, PDGFRA, RAB4A, EEA1, USP8, RAB11B, ZFYVE16
|
0.003294 |
| Calcium signaling pathway |
10 genes: CHRM3, ERBB4, GRIN2A, MYLK, PDE1C, PDGFRA, PLCB4, PRKACB, BST1, CACNA1C
|
0.003708 |
| MAPK signaling pathway |
13 genes: FGF2, FGF7, FGF12, FGF13, MEF2C, PDGFRA, PPM1A, PRKACB, RAP1A, RAP1B, CACNA1C, CACNB2, MAP4K3
|
0.003808 |
| Gastric acid secretion |
6 genes: CHRM3, SLC26A7, KCNJ16, MYLK, PLCB4, PRKACB
|
0.004149 |
| Regulation of actin cytoskeleton |
11 genes: CFL2, CHRM3, DOCK1, FGF2, FGF7, FGF12, FGF13, MYLK, PPP1R12A, PDGFRA, PPP1CC
|
0.004896 |
| Hedgehog signaling pathway |
5 genes: RAB23, PRKACB, PTCH1, HHIP, SMO
|
0.005785 |
| PI3K AKT signaling pathway |
15 genes: FGF2, FGF7, FGF12, FGF13, IGF1, HGF, INSR, PDGFRA, KIT, COL4A4, COL9A1, LPAR1, PRKAA2, CCND2, FOXO3
|
0.006318 |
| Vascular smooth muscle contraction |
7 genes: MYLK, PPP1R12A, PLCB4, PPP1CC, PRKACB, PRKCE, CACNA1C
|
0.01011 |
| Nicotinate and nicotinamide metabolism |
3 genes: ENPP1, BST1, NUDT12
|
0.01266 |
| Wnt signaling pathway |
8 genes: NFAT5, PRICKLE2, SMAD4, PLCB4, PRKACB, FZD3, FZD4, CCND2
|
0.01296 |
| Hippo signaling pathway |
8 genes: AMOT, PPP1CC, TEAD1, SMAD4, BMPR2, FZD3, FZD4, CCND2
|
0.01445 |
| Melanogenesis |
6 genes: KIT, MITF, PLCB4, PRKACB, FZD3, FZD4
|
0.01795 |
| Insulin signaling pathway |
7 genes: FOXO1, INSR, PPP1CC, PRKAA2, PRKAB2, PRKACB, PRKAR2B
|
0.02407 |
| TGF.beta signaling pathway |
5 genes: INHBB, SMAD4, SMAD9, BMPR2, ZFYVE16
|
0.03079 |